Steve Arshinoff, MD MD
Steve A. Arshinoff MD FRCSC was born in Montreal, Quebec, Canada, graduated in Medicine from Baylor College of Medicine, in Houston, Texas, and completed his ophthalmic training at The University of Toronto, Canada, where he is Professor, Department of Ophthalmology and Vision Sciences. His areas of research interest include ophthalmic viscosurgical devices and related surgical techniques, phacoemulsification machine design, immediately sequential bilateral cataract surgery, post-operative endophthalmitis prophylaxis, and medical outreach programs. He is on the Editorial Board of the Journal of Cataract and Refractive Surgery and has authored more than 300 peer-reviewed publications, 38 medical textbook chapters and 1 book (Immediately Sequential Bilateral Cataract Surgery). He has presented >1,100 academic lectures worldwide. Dr. Arshinoff is the designer of the OMA-CNIB (Ontario Medical Association - Canadian National Institute for the Blind) Mobile Medical Eye Care Unit (MMECU) and is the medical director of this program to the North of Ontario, Canada (an area = 1.25 x Texas). He is the Founding President of the Toronto Ophthalmological Society, the Eye Foundation of Canada, and the International Society of Bilateral Cataract Surgeons (iSBCS) and is a Past President of the International Intra-ocular Implant Club, the parent society of the American, European and all other Societies of Cataract and Refractive Surgery globally.
Financial disclosure: Dr. Arshinoff has/had an affiliation (financial or otherwise) with a commercial organization:
1. Alcon
2. Entod Pharmaceuticals
3. I-Med Pharmaceuticals
4. Zeiss
5. Rayner
6. ArcticDx
Sessions in which Steve Arshinoff, MD MD participates
Sunday 16 June, 2019
Saturday 11 June, 2022
Thursday 8 September, 2022
Friday 20 June, 2025
Author’s Name(s): Steve Arshinoff, Runjie Bill Shi, Brenda TaoAuthor’s Disclosure Block: Steve Arshinoff: Alcon, Employment/honoraria/consulting fees, BVI, Employment/honoraria/consulting fees, Bohus Biotech, Employment/honoraria/consulting fees, Rayner, Employment/honoraria/consulting fees, carl Zeiss Meditech, Employment/honoraria/consulting fees; Runjie Bill Shi: none; Brenda Tao: noneAbstract BodyPurpose:To determine the...
Sessions in which Steve Arshinoff, MD MD attends
Thursday 15 June, 2023
Please join us for a glass of cheer and help us celebrate the 2023 COS Annual Meeting and Exhibition. This event is a great opportunity to network with our international speakers, special guests, sponsors, and exhibitors. Renew old acquaintances and make new friends with colleagues from across Canada.
Friday 16 June, 2023
*Breakfast to be served from 6:00am* Learning Objectives:At the end of this session, participants will be able to:Identify innovative canadian retina research proposalsand their intended benefitDescribe how using emerging therapies can improvethe care of patientsCanMEDS Roles: Medical Expert, Scholar
Learning Objectives:At the end of this session, participants will be able to:Review how to apply Quality Improvement strategies to improve patient safetyBe familiar with the presentation and histology of hereditary benign intraepithelial dyskeratosis, and be able to distinguish it from other conjunctival lesions including conjunctival intraepithelial neoplasia.Des...
Learning Objectives: At the end of this session, participants will be able to: Explore new IOL technology and biometryDiscuss the use of toric IOLsReview pearls for cataract surgery after phakic IOLsCanMEDS Roles: Medical expert, scholarXX
Learning Objectives:At the end of this session, participants will be able to: Review common comorbid conditions present in cataract patientsDiscuss risk communication in cataract surgeryExplore the role of ergonomics in the workplace CanMEDS Roles: Medical expert, scholarXX
Authors: Steve A. Arshinoff . University of Toronto. Author Disclosures: Steve Arshinoff: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Alcon, Zeiss, Rayner, Cima, Arctic Dx. Any direct financial payments including receipt of honoraria; Description of relationship(s); consultant. Abstract Body:
Learning Objectives:At the end of this session, participants will be able to: Review the history and patient perceptions of ISBCSExplore the trends in IOL strategiesDiscuss premium cataract refractive surgery CanMEDS Roles: Medical expert, scholarXX
Saturday 17 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX
Learning ObjectivesAt the end of this session, participants will be able to:Describe how cultured corneal endothelial cells can be used to treat corneal endothelial failureDescribe how the corneal neurotinization procedure is performed and compare with other treatment modalities for treating neurotrophic corneal ulcersDescribe how cultivated oral mucosal epithelial transplantation can be used to treat patients with Stevens-...
Learning Objectives: At the end of this session, participants will be able to: Enhance surgical strategies for routine cataractsDevelop an approach to complex cataract surgery: techniques, strategies, and instrumentationCanMEDS Roles: Medical expert, scholarX
Authors (233 & 238): Miguel Angel Hernandez-Delgado1, Yuridia Garcia-Espindola2, Mélanie Hébert3. 1Instituto Tecnologico y de Estudios Superiores de Monterrey, 2 Universidad Michoacana de San Nicolas de Hidalgo, 3Department of Ophthalmology, Hôpital Saint-Sacrement, CHU de Québec - Université Laval.Author Disclosures (233 & 238): M.A. Hernand...
Sunday 18 June, 2023
Authors: Mélanie Hébert1, Ryan Hendrick2, Keith Perry2, Mohammed Al-Kaabi3, Anna Polosa3, Marie-Josée Aubin3. 1Hôpital Saint-Sacrement, CHU de Québec - Université Laval, 2Université de Montréal, 3Centre universitaire d'ophtalmologie, Hôpital Maisonneuve-Rosemont.Author Disclosures: M. Hébert: Funded grants or clinical ...